Citigroup Inc Aspira Women'S Health Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.4 - $1.09 $744 - $2,028	1,861 Added 27.05%	8,741 $5,000
Q1 2022 May 12, 2022	SELL	$0.88 - $1.81 $10,949 - $22,521	-12,443 Reduced 64.39%	6,880 $7,000
Q4 2021 Feb 10, 2022	BUY	$1.63 - $3.43 $16,482 - $34,684	10,112 Added 109.78%	19,323 $34,000
Q3 2021 Nov 10, 2021	BUY	$3.19 - $5.48 $29,383 - $50,476	9,211 New	9,211 $30,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.